Suppr超能文献

卡波西肉瘤相关疱疹病毒的病毒干扰素调节因子在其抑制 Toll 样受体 3 介导的干扰素激活方面存在差异。

The viral interferon regulatory factors of kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by toll-like receptor 3.

机构信息

Lineberger Comprehensive Cancer Center and Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

J Virol. 2013 Jan;87(2):798-806. doi: 10.1128/JVI.01851-12. Epub 2012 Oct 31.

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) infection is correlated with three human malignancies and can establish lifelong latent infection in multiple cell types within its human host. In order to establish and maintain infection, KSHV utilizes multiple mechanisms to evade the host immune response. One such mechanism is the expression of a family of genes with homology to cellular interferon (IFN) regulatory factors (IRFs), known as viral IRFs (vIRFs). We demonstrate here that KSHV vIRF1, -2, and -3 have a differential ability to block type I interferon signaling mediated by Toll-like receptor 3 (TLR3), a receptor we have previously shown to be activated upon KSHV infection. vIRF1, -2, and -3 inhibited TLR3-driven activation of IFN transcription reporters. However, only vIRF1 and vIRF2 inhibited increases in both IFN-β message and protein levels following TLR3 activation. The expression of vIRF1 and vIRF2 also allowed for increased replication of a virus known to activate TLR3 signaling. Furthermore, vIRF1 and vIRF2 may block TLR3-mediated signaling via different mechanisms. Altogether, this report indicates that vIRFs are able to block IFN mediated by TLRs but that each vIRF has a unique function and mechanism for blocking antiviral IFN responses.

摘要

卡波济肉瘤相关疱疹病毒(KSHV)感染与三种人类恶性肿瘤相关,并可在其人类宿主的多种细胞类型中建立终身潜伏感染。为了建立和维持感染,KSHV 利用多种机制来逃避宿主的免疫反应。其中一种机制是表达一系列与细胞干扰素(IFN)调节因子(IRF)具有同源性的基因,称为病毒 IRF(vIRF)。我们在此证明,KSHV vIRF1、-2 和 -3 具有不同的能力来阻断 Toll 样受体 3(TLR3)介导的 I 型干扰素信号,我们之前已经证明 TLR3 在 KSHV 感染时被激活。vIRF1、-2 和 -3 抑制 TLR3 驱动的 IFN 转录报告基因的激活。然而,只有 vIRF1 和 vIRF2 抑制 TLR3 激活后 IFN-β 信使和蛋白水平的增加。vIRF1 和 vIRF2 的表达也允许激活 TLR3 信号的病毒复制增加。此外,vIRF1 和 vIRF2 可能通过不同的机制阻断 TLR3 介导的信号。总之,本报告表明 vIRF 能够阻断 TLR 介导的 IFN,但每个 vIRF 都有阻止抗病毒 IFN 反应的独特功能和机制。

相似文献

7
Viral interferon regulatory factors.病毒干扰素调节因子。
J Interferon Cytokine Res. 2009 Sep;29(9):621-7. doi: 10.1089/jir.2009.0067.

引用本文的文献

4
Molecular Mechanisms of Kaposi Sarcoma Development.卡波西肉瘤发生的分子机制
Cancers (Basel). 2022 Apr 7;14(8):1869. doi: 10.3390/cancers14081869.
6
Castleman disease.卡斯尔曼病。
Nat Rev Dis Primers. 2021 Nov 25;7(1):84. doi: 10.1038/s41572-021-00317-7.
9
Activation and Evasion of Innate Immunity by Gammaherpesviruses.γ疱疹病毒对固有免疫的激活与逃逸。
J Mol Biol. 2022 Mar 30;434(6):167214. doi: 10.1016/j.jmb.2021.167214. Epub 2021 Aug 23.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验